長期投資家のためのIR情報
バリュートレンド

【4528】小野薬品工業
製薬。がん免疫薬『オプジーボ』。

業績予想修正履歴

決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2024.03 2024/01/31 Q3予 500,000 0.0% +5.3% 167,000 0.0% +9.2% 169,000 0.0% +9.7% 126,000 0.0% +9.6%
2024.03 2023/11/01 Q2予 500,000 +5.3% +5.3% 167,000 +9.2% +9.2% 169,000 +9.7% +9.7% 126,000 +9.6% +9.6%
2024.03 2023/07/31 Q1予 475,000 0.0% 0.0% 153,000 0.0% 0.0% 154,000 0.0% 0.0% 115,000 0.0% 0.0%
2024.03 2023/05/10 当初予 475,000 - - - 153,000 - - - 154,000 - - - 115,000 - - -
2023.03 2023/05/10 447,187 +1.6% +5.2% 141,963 -4.7% -2.1% 143,532 -4.3% -1.7% 112,723 -1.1% +2.5%
2023.03 2023/01/31 Q3予 440,000 0.0% +3.5% 149,000 0.0% +2.8% 150,000 0.0% +2.7% 114,000 0.0% +3.6%
2023.03 2022/10/31 Q2予 440,000 +3.5% +3.5% 149,000 +2.8% +2.8% 150,000 +2.7% +2.7% 114,000 +3.6% +3.6%
2023.03 2022/08/01 Q1予 425,000 0.0% 0.0% 145,000 0.0% 0.0% 146,000 0.0% 0.0% 110,000 0.0% 0.0%
2023.03 2022/05/11 当初予 425,000 - - - 145,000 - - - 146,000 - - - 110,000 - - -
2022.03 2022/05/11 361,361 +0.4% +3.2% 103,195 -3.6% -1.7% 105,025 -3.6% -1.8% 80,519 -3.0% -3.0%
2022.03 2022/01/31 Q3予 360,000 +4.3% +2.9% 107,000 +3.9% +1.9% 109,000 +3.8% +1.9% 83,000 +1.8% 0.0%
2022.03 2021/11/01 Q2予 345,000 0.0% -1.4% 103,000 0.0% -1.9% 105,000 0.0% -1.9% 81,500 0.0% -1.8%
2022.03 2021/07/30 Q1予 345,000 0.0% -1.4% 103,000 0.0% -1.9% 105,000 0.0% -1.9% 81,500 0.0% -1.8%
2022.03 2021/05/13 修正予 345,000 -1.4% -1.4% 103,000 -1.9% -1.9% 105,000 -1.9% -1.9% 81,500 -1.8% -1.8%
2022.03 2021/05/11 当初予 350,000 - - - 105,000 - - - 107,000 - - - 83,000 - - -
2021.03 2021/05/11 309,284 +0.1% +2.1% 98,330 +4.6% +22.9% 100,890 +5.6% +23.0% 75,425 +1.9% +23.6%
2021.03 2021/02/01 Q3予 309,000 +1.3% +2.0% 94,000 +8.0% +17.5% 95,500 +7.9% +16.5% 74,000 +13.8% +21.3%
2021.03 2020/10/29 Q2予 305,000 +0.7% +0.7% 87,000 +8.7% +8.7% 88,500 +7.9% +7.9% 65,000 +6.6% +6.6%
2021.03 2020/07/31 Q1予 303,000 - - - 80,000 - - - 82,000 - - - 61,000 - - -
2020.03 2020/05/12 修正予 303,000 +4.5% +4.5% 80,000 +12.7% +19.4% 82,000 +12.3% +17.1% 61,000 +10.9% +15.1%
2020.03 2020/01/31 Q3予 290,000 0.0% 0.0% 71,000 +6.0% +6.0% 73,000 +4.3% +4.3% 55,000 +3.8% +3.8%
2020.03 2019/10/31 Q2予 290,000 0.0% 0.0% 67,000 0.0% 0.0% 70,000 0.0% 0.0% 53,000 0.0% 0.0%
2020.03 2019/08/01 Q1予 290,000 0.0% 0.0% 67,000 0.0% 0.0% 70,000 0.0% 0.0% 53,000 0.0% 0.0%
2020.03 2019/05/09 当初予 290,000 - - - 67,000 - - - 70,000 - - - 53,000 - - -
2019.03 2019/05/09 288,634 +3.1% +4.2% 62,010 -2.3% +0.8% 65,141 -2.8% +0.2% 51,539 -0.9% +2.1%
2019.03 2019/02/01 Q3予 280,000 0.0% +1.1% 63,500 0.0% +3.3% 67,000 0.0% +3.1% 52,000 0.0% +3.0%
2019.03 2018/11/01 Q2予 280,000 +1.1% +1.1% 63,500 +3.3% +3.3% 67,000 +3.1% +3.1% 52,000 +3.0% +3.0%
2019.03 2018/08/01 Q1予 277,000 0.0% 0.0% 61,500 0.0% 0.0% 65,000 0.0% 0.0% 50,500 0.0% 0.0%
2019.03 2018/05/10 当初予 277,000 - - - 61,500 - - - 65,000 - - - 50,500 - - -
2018.03 2018/05/10 261,836 +0.7% +10.9% 60,684 +11.3% +66.3% 63,922 +11.2% +63.9% 50,284 +16.9% +73.4%
2018.03 2018/02/02 Q3予 260,000 +2.4% +10.2% 54,500 +9.0% +49.3% 57,500 +8.5% +47.4% 43,000 +8.9% +48.3%
2018.03 2017/11/06 Q2予 254,000 +7.6% +7.6% 50,000 +37.0% +37.0% 53,000 +35.9% +35.9% 39,500 +36.2% +36.2%
2018.03 2017/08/02 Q1予 236,000 0.0% 0.0% 36,500 0.0% 0.0% 39,000 0.0% 0.0% 29,000 0.0% 0.0%
2018.03 2017/05/11 当初予 236,000 - - - 36,500 - - - 39,000 - - - 29,000 - - -
2017.03 2017/05/11 244,797 +2.0% -5.5% 72,284 +5.5% -0.3% 74,540 +5.7% -0.6% 55,793 +6.7% -0.0%
2017.03 2017/02/02 Q3予 240,000 0.0% -7.3% 68,500 +26.9% -5.5% 70,500 +25.9% -6.0% 52,300 +25.1% -6.3%
2017.03 2016/12/21 修正予 240,000 -7.3% -7.3% 54,000 -25.5% -25.5% 56,000 -25.3% -25.3% 41,800 -25.1% -25.1%
2017.03 2016/11/07 Q2予 259,000 0.0% 0.0% 72,500 0.0% 0.0% 75,000 0.0% 0.0% 55,800 0.0% 0.0%
2017.03 2016/08/02 当初予 259,000 - - - 72,500 - - - 75,000 - - - 55,800 - - -
2016.03 2016/05/11 - - - - - - - - - - - - - - - -
2016.03 2016/05/06 修正予 160,000 +2.6% +18.4% 30,000 +25.0% +114.3% 33,000 +24.5% +100.0% 25,000 +34.4% +115.5%
2016.03 2016/02/02 Q3予 156,000 +8.0% +15.5% 24,000 +57.9% +71.4% 26,500 +48.9% +60.6% 18,600 +42.0% +60.3%
2016.03 2015/11/04 Q2予 144,500 +7.0% +7.0% 15,200 +8.6% +8.6% 17,800 +7.9% +7.9% 13,100 +12.9% +12.9%
2016.03 2015/08/04 Q1予 135,100 0.0% 0.0% 14,000 - - - 16,500 0.0% 0.0% 11,600 0.0% 0.0%
2016.03 2015/05/12 当初予 135,100 - - - - - - - 16,500 - - - 11,600 - - -
2015.03 2015/05/12 - - - - - - - - - - - - - - - -
2015.03 2015/02/03 Q3予 137,000 +5.9% -1.4% 15,100 +15.3% -21.4% 17,700 +12.7% -18.8% 12,000 +10.1% -25.0%
2015.03 2014/11/05 Q2予 129,400 -6.9% -6.9% 13,100 -31.8% -31.8% 15,700 -28.0% -28.0% 10,900 -31.9% -31.9%
2015.03 2014/08/04 Q1予 139,000 0.0% 0.0% 19,200 0.0% 0.0% 21,800 0.0% 0.0% 16,000 0.0% 0.0%
2015.03 2014/05/13 当初予 139,000 - - - 19,200 - - - 21,800 - - - 16,000 - - -
2014.03 2014/05/13 143,247 -3.4% -3.4% 26,423 -5.3% -5.3% 29,458 +1.6% +1.6% 20,350 -0.2% -0.2%
2014.03 2014/02/04 当初予 148,300 - - - 27,900 - - - 29,000 - - - 20,400 - - -
ページトップへ戻る